# FDA recall D-0417-2025

> **L'Oreal USA** · Class II · drug recall initiated 2025-03-05.

## Product

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

## Reason for recall

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0417-2025
- **Recalling firm:** L'Oreal USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-03-05
- **Report date:** 2025-05-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Clark, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0417-2025

## Citation

> AI Analytics. FDA recall D-0417-2025. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0417-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*